Home

celecoxib or diclofenac

Celecoxib versus Diclofenac and Omeprazole in Reducing the Risk of  Recurrent Ulcer Bleeding in Patients with Arthritis | NEJM
Celecoxib versus Diclofenac and Omeprazole in Reducing the Risk of Recurrent Ulcer Bleeding in Patients with Arthritis | NEJM

Blood pressure effects of celecoxib vs diclofenac or ibuprofen | Download  Table
Blood pressure effects of celecoxib vs diclofenac or ibuprofen | Download Table

Celecoxib versus diclofenac for the treatment of ankylosing spondylitis:  12-week randomized study in Norwegian patients – topic of research paper in  Clinical medicine. Download scholarly article PDF and read for free on
Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on

Structure of Celecoxib, Diclofenac and target compound | Download  Scientific Diagram
Structure of Celecoxib, Diclofenac and target compound | Download Scientific Diagram

Celecoxib and Diclofenac Plus Omeprazole are Similarly Effective in the  Treatment of Arthritis in Patients at High GI Risk in the CONDOR Trial
Celecoxib and Diclofenac Plus Omeprazole are Similarly Effective in the Treatment of Arthritis in Patients at High GI Risk in the CONDOR Trial

Hot Topics in Gastroenterology: Management of Nonselective NSAID-Related  Toxicity Up and Down the GI Tract
Hot Topics in Gastroenterology: Management of Nonselective NSAID-Related Toxicity Up and Down the GI Tract

Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis  and rheumatoid arthritis (CONDOR): a randomised trial | Semantic Scholar
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial | Semantic Scholar

Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response  considerations and fair play in comparative trials - Stiller - 2022 -  Journal of Internal Medicine - Wiley Online Library
Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials - Stiller - 2022 - Journal of Internal Medicine - Wiley Online Library

Pharmaceutics | Free Full-Text | Anti-Psoriasis Effect of Diclofenac and  Celecoxib Using the Tail Model for Psoriasis
Pharmaceutics | Free Full-Text | Anti-Psoriasis Effect of Diclofenac and Celecoxib Using the Tail Model for Psoriasis

Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis  and rheumatoid arthritis (CONDOR): a randomised trial | Semantic Scholar
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial | Semantic Scholar

Celecoxib versus diclofenac for the treatment of ankylosing spondylitis:  12-week randomized study in Norwegian patients - Chris Walker, Margaret N  Essex, Chunming Li, Peter W Park, 2016
Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients - Chris Walker, Margaret N Essex, Chunming Li, Peter W Park, 2016

Celecoxib versus diclofenac in long-term management of rheumatoid  arthritis: randomised double-blind comparison | Semantic Scholar
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar

Celecoxib versus diclofenac for stroke. | Download Scientific Diagram
Celecoxib versus diclofenac for stroke. | Download Scientific Diagram

Diclofenac but not celecoxib improves endothelial function in rheumatoid  arthritis: A study in adjuvant-induced arthritis - ScienceDirect
Diclofenac but not celecoxib improves endothelial function in rheumatoid arthritis: A study in adjuvant-induced arthritis - ScienceDirect

Indirect comparison of NSAIDs for ankylosing spondylitis: Network  meta‑analysis of randomized, double‑blinded, controlled trials
Indirect comparison of NSAIDs for ankylosing spondylitis: Network meta‑analysis of randomized, double‑blinded, controlled trials

Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis  and rheumatoid arthritis (CONDOR): a randomised trial - The Lancet
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial - The Lancet

Cardiorenal effects of celecoxib as compared with the nonsteroidal  anti-inflammatory drugs diclofenac and ibuprofen - ScienceDirect
Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen - ScienceDirect

Celecoxib versus diclofenac for major vascular events. CI, confidence... |  Download Scientific Diagram
Celecoxib versus diclofenac for major vascular events. CI, confidence... | Download Scientific Diagram

Contrasting effects of diclofenac and ibuprofen on active imatinib uptake  into leukaemic cells | British Journal of Cancer
Contrasting effects of diclofenac and ibuprofen on active imatinib uptake into leukaemic cells | British Journal of Cancer

Effects of COX Inhibition on Blood Pressure and Kidney Function in ACE  Inhibitor-Treated Blacks and Hispanics | Hypertension
Effects of COX Inhibition on Blood Pressure and Kidney Function in ACE Inhibitor-Treated Blacks and Hispanics | Hypertension

Celecoxib versus Diclofenac and Omeprazole in Reducing the Risk of  Recurrent Ulcer Bleeding in Patients with Arthritis | NEJM
Celecoxib versus Diclofenac and Omeprazole in Reducing the Risk of Recurrent Ulcer Bleeding in Patients with Arthritis | NEJM

Celecoxib versus diclofenac in long-term management of rheumatoid  arthritis: randomised double-blind comparison - The Lancet
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison - The Lancet

Celecoxib for arthritis relief less likely to cause gastrointestinal damage  than diclofenac + omeprazole
Celecoxib for arthritis relief less likely to cause gastrointestinal damage than diclofenac + omeprazole